A Methadone Maintenance Treatment Outcome Study in Three Provinces in China

Sponsor
Centers for Disease Control and Prevention (U.S. Fed)
Overall Status
Unknown status
CT.gov ID
NCT01315054
Collaborator
National Center for AIDS/STD Control and Prevention, China CDC (Other)
7,700
1
3
43
178.9

Study Details

Study Description

Brief Summary

Methadone treatment has became one of main actions taken in China to control the spread of HIV among drug users. However,the average methadone dose used is relatively low. An intensive methadone maintenance treatment (MMT) provider training on methadone dosage may be effective in increasing the methadone dose levels prescribed to new patients. The study will evaluate the effectiveness of a tailored education program for MMT service providers using subsequent methadone dose prescribed to new patients. The effects of methadone dose, with and without the inclusion of additional psychosocial services, will then be measured through MMT retention and illicit opioid use.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: MMT provider dosage training
  • Behavioral: targeted counseling
  • Other: national guidelines
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
7700 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
A Methadone Maintenance Treatment Outcome Study in Three Provinces in China: Comparative Evaluation of the Impact of an Intensive Health Care Provider Training Program Combined With Expanded Services on Treatment Retention, Heroin Use, Methadone Dosing and HIV Risk Practices
Study Start Date :
May 1, 2011
Anticipated Primary Completion Date :
Dec 1, 2014
Anticipated Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Other: Control arm

Using currently practiced methadone dosage prescription methods

Other: national guidelines
Provided a hard copy of the existing national guidelines for methadone dosing
Other Names:
  • dosing guidelines
  • Experimental: MMT provider dosage training

    Intensive health care provider training on prescribing methadone dosage based on national guidelines

    Behavioral: MMT provider dosage training
    Training on methadone dosing provided to health care providers working in methadone maintenance clinics
    Other Names:
  • training
  • Other: national guidelines
    Provided a hard copy of the existing national guidelines for methadone dosing
    Other Names:
  • dosing guidelines
  • Experimental: MMT provider dosage training/counseling

    Intensive health care provider training on prescribing methadone dosage, plus providing on-site psychosocial counseling services and peer support to clients .

    Behavioral: MMT provider dosage training
    Training on methadone dosing provided to health care providers working in methadone maintenance clinics
    Other Names:
  • training
  • Behavioral: targeted counseling
    targeted counseling provided to methadone maintenance clinic attendees
    Other Names:
  • counseling
  • Other: national guidelines
    Provided a hard copy of the existing national guidelines for methadone dosing
    Other Names:
  • dosing guidelines
  • Outcome Measures

    Primary Outcome Measures

    1. MMT retention rate [12 months]

    2. Illicit opioid use rate [12 months]

      by urinalysis and self-report

    Secondary Outcome Measures

    1. HIV, HCV, syphilis and HSV-2 infection seroconversion rate [12 months]

    2. High risk needle practice [12 months]

    3. High risk sexual practice [12 months]

    4. Quality of life(WHO Quality of Life -BREF) [12 months]

    5. All-cause mortality [12 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • client participants will include both men and women who are opiate-dependent drug users who started MMT not more than one month prior to enrollment in the study

    • 18 years of age or older

    • residing in the study areas

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 National Center for HIV/STD Prevention and Control, China CDC Beijing China 100050

    Sponsors and Collaborators

    • Centers for Disease Control and Prevention
    • National Center for AIDS/STD Control and Prevention, China CDC

    Investigators

    • Principal Investigator: Marc Bulterys, MD, PhD, US CDC GAP China

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Centers for Disease Control and Prevention
    ClinicalTrials.gov Identifier:
    NCT01315054
    Other Study ID Numbers:
    • CDC-CGH-6014
    • CN_09_217
    First Posted:
    Mar 15, 2011
    Last Update Posted:
    Mar 17, 2014
    Last Verified:
    Apr 1, 2012
    Keywords provided by Centers for Disease Control and Prevention
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 17, 2014